World Investment Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.88M Sell
29,273
-461
-2% -$99.3K 0.1% 227
2026
Q1
$5.97M Buy
29,734
+21,817
+276% +$4.51M 0.1% 227
2025
Q4
$1.63M Sell
7,917
-156
-2% -$31.2K 0.03% 531
2025
Q3
$1.45M Sell
8,073
-61
-0.7% -$10.4K 0.03% 476
2025
Q2
$1.31M Buy
8,134
+323
+4% +$51.5K 0.03% 459
2025
Q1
$1.33M Buy
7,811
+665
+9% +$115K 0.03% 434
2024
Q4
$1.19M Buy
7,146
+5,029
+238% +$859K 0.03% 433
2024
Q3
$364K Buy
2,117
+10
+0.5% +$1.66K 0.01% 675
2024
Q2
$321K Buy
+2,107
New +$316K 0.02% 483

Other funds holding FBT

World Investment Advisors's FBT Position: Q2 2026 in Review

World Investment Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.6% in Q2 2026, selling an estimated $99.3K and leaving 29,273 shares worth $5.88M. The position accounts for 0.1% of the portfolio, ranked #227.

World Investment Advisors first reported a position in FBT in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.97M in Q1 2026. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • World Investment Advisors held 29,273 shares of First Trust NYSE Arca Biotechnology Index Fund worth $5.88M as of Q2 2026.
  • World Investment Advisors sold 461 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $99.3K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.1% of World Investment Advisors's portfolio in Q2 2026, its #227 holding.
  • World Investment Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2024 and has held it in 9 quarters since.
  • World Investment Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $5.97M in Q1 2026.
  • 340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.